Bml Capital Management, LLC An2 Therapeutics, Inc. Transaction History
Bml Capital Management, LLC
- $161 Billion
- Q4 2024
A detailed history of Bml Capital Management, LLC transactions in An2 Therapeutics, Inc. stock. As of the latest transaction made, Bml Capital Management, LLC holds 5,749,432 shares of ANTX stock, worth $6.5 Million. This represents 4.93% of its overall portfolio holdings.
Number of Shares
5,749,432
Previous 5,749,432
-0.0%
Holding current value
$6.5 Million
Previous $6.15 Billion
28.97%
% of portfolio
4.93%
Previous 3.62%
Shares
1 transactions
Others Institutions Holding ANTX
# of Institutions
38Shares Held
13.8MCall Options Held
0Put Options Held
0-
Almitas Capital LLC Santa Monica, CA1.31MShares$1.48 Million0.87% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.04MShares$1.17 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny580KShares$655,1430.0% of portfolio
-
Peapod Lane Capital LLC Bedford Hills, NY579KShares$654,0720.79% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny528KShares$596,9790.0% of portfolio
About AN2 Therapeutics, Inc.
- Ticker ANTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 19,402,700
- Market Cap $21.9M
- Description
- AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menl...